MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/1354750x.2018.1468825

Медицинская библиотека · Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2018

Comparison of β2-microglobulin serum level between Alzheimer's patients, cognitive healthy and mild cognitive impaired individuals.

Dominici Roberto, Finazzi Dario, Polito Letizia, Oldoni Emanuela, Bugari Giovanna, Montanelli Alessandro, Scarpini Elio, Galimberti Daniela, Guaita Antonio

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Several studies performed in the last years on the brain, showed that beta2-microglobulin (β2m) and MHC can act independently of their canonical immune function to regulate normal brain development, synaptic plasticity and behaviour. Increased systemic levels of soluble β2m have been implicated in cognitive impairments like that associated with chronic haemodialysis, or aortic valve replacement. Increased soluble β2m has also been detected in the cerebral spinal fluid (CSF) of patients with HIV-associated dementia and Alzheimer's disease (AD).

OBJECTIVE

To compare plasma β2m levels in healthy subjects and subjects with dementia or cognitive impairment.

METHODS

We measured the concentration of β2m in a cohort of 245 individuals and compared sex matched, cognitive healthy individuals.

RESULTS

We found higher levels of β2m in AD patients compared to non-AD MCI and healthy controls (2063 ng/mL ±852 versus 1613 ± 503 and 1832 ± 382 ng/mL, p< 0.001 and <0.033, respectively), while there was no difference between mild cognitive impairment (MCI) and healthy controls (p > 0.05).

CONCLUSIONS

Our data confirm that β2m could play a role in AD. However, a replication study in an independent cohort would be necessary to confirm our preliminary results.

Для цитирования: Dominici Roberto, Finazzi Dario, Polito Letizia, Oldoni Emanuela, Bugari Giovanna, Montanelli Alessandro, Scarpini Elio, Galimberti Daniela, Guaita Antonio. Comparison of β2-microglobulin serum level between Alzheimer's patients, cognitive healthy and mild cognitive impaired individuals.. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2018. DOI: 10.1080/1354750x.2018.1468825.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.